Simulations Plus (NASDAQ:SLP) Sets New 12-Month Low - Should You Sell?

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $24.00 and last traded at $24.96, with a volume of 95166 shares changing hands. The stock had previously closed at $24.68.

Wall Street Analysts Forecast Growth

SLP has been the topic of a number of analyst reports. William Blair reissued an "outperform" rating on shares of Simulations Plus in a research note on Wednesday, January 8th. KeyCorp lifted their price objective on Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Simulations Plus currently has an average rating of "Moderate Buy" and an average target price of $49.40.

Simulations Plus Stock Down 3.0 %

The stock has a fifty day moving average of $31.23 and a 200-day moving average of $30.79. The firm has a market capitalization of $497.62 million, a P/E ratio of 62.31 and a beta of 0.89.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 19.40% of the company's stock.

Remove Ads

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SLP. First Horizon Advisors Inc. boosted its position in shares of Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares in the last quarter. Jones Financial Companies Lllp increased its position in shares of Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after acquiring an additional 427 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Simulations Plus during the fourth quarter worth $39,000. Quantbot Technologies LP bought a new stake in Simulations Plus in the 3rd quarter valued at $59,000. Finally, Tower Research Capital LLC TRC boosted its stake in Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.